Skip to content

Newsroom

type
year
Illustration image.png

Orion publishes Interim Report for January–March 2024 and holds a webcast on 25 April 2024

4/11/2024 Press release
Illustration image.png

The change negotiations concerning Orion’s Kuopio plant have been concluded – the company has decided to continue to explore the outsourcing of production at the plant

3/22/2024 Press release
Illustration image.png

Orion and Save the Children Finland announce cooperation to promote well-being of children in Finland and globally

2/22/2024 Press release
Illustration image.png

Orion to investigate the possible outsourcing of its pharmaceutical production in Kuopio, Finland

2/19/2024 Press release
Illustration image.png

Orion publishes Financial Statement Release for 2023 and holds a webcast on 13 February 2024

1/29/2024 Press release
Illustration image.png

Orion Corporation and Newel Health enter into licensing agreement for a digital therapeutic (DTx) ODD-403 (“Rohkea”) in pain

1/29/2024 Press release
Illustration image.png

Additional ODM-208/MK-5684 Phase II data presented at ASCO-GU 2024

1/26/2024 Press release
Illustration image.png

Orion and Glykos announce research collaboration and licensing agreement to develop next-generation ADCs

1/8/2024 Press release
Illustration image.png

Orion and MSD Announce Initiation of Two Phase 3 Trials Evaluating ODM-208/MK5684 in Certain Patients with Metastatic Castration-Resistant Prostate Cancer

1/5/2024 Press release
Illustration image.png

NEJM Evidence publishes results from Phase I/IIa CYPIDES trial with ODM-208

12/27/2023 Press release
Illustration image.png

Phase 3 Clinical Trials with ODM-208 (MK-5684) posted to ClinicalTrials.gov database

11/21/2023 Press release
Illustration image.png

Orion Animal Health receives FDA approval for Bonqat® (pregabalin oral solution)

11/20/2023 Press release
Illustration image.png

Orion Research Foundation grants EUR 1,112,000 for research in 2024

11/15/2023 Press release
Illustration image.png

Orion publishes Interim Report for January–September 2023 on Thursday 26 October 2023

10/16/2023 Press release
Illustration image.png

European Commission approval of Ztalmy® (ganaxolone) for the adjunctive treatment of epileptic seizures associated with CDKL5 deficiency disorder

7/31/2023 Press release
Illustration image.png

Orion publishes Half-Year Financial Report for January–June 2023 on Monday 17 July 2023

7/4/2023 Press release
Illustration image.png

Orion invests EUR 30 million to increase production capacity in Finland

6/28/2023 Press release
Illustration image.png

Orion hosts its Capital Markets Day today, May 25, 2023, in Helsinki

5/25/2023 Press release